BeOne Medicines
ONC
#583
Rank
$42.96 B
Marketcap
$377.63
Share price
-1.21%
Change (1 day)
21.50%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Half-year Reports

Thumbnail BeOne Medicines Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report